U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 009388
Company: TEVA WOMENS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DIAMOX ACETAZOLAMIDE SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** INJECTABLE;INJECTION Discontinued None Yes No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
06/25/1954 ORIG-1 Approval Type 3 - New Dosage Form STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
05/13/2022 SUPPL-38 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008943s052,009388s038lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/008943Orig1s052; 009388Orig1s038ltr.pdf
11/26/2002 SUPPL-35 Manufacturing (CMC)-Control

Label is not available on this site.

12/03/1999 SUPPL-33 Manufacturing (CMC)-Control

Label is not available on this site.

09/06/2000 SUPPL-32 Manufacturing (CMC)

Label is not available on this site.

07/01/1994 SUPPL-31 Manufacturing (CMC)-Control

Label is not available on this site.

07/01/1994 SUPPL-30 Labeling

Label is not available on this site.

12/09/1993 SUPPL-29 Manufacturing (CMC)-Control

Label is not available on this site.

12/13/1990 SUPPL-28 Manufacturing (CMC)-Control

Label is not available on this site.

12/05/1990 SUPPL-25 Labeling

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
05/13/2022 SUPPL-38 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/008943s052,009388s038lbl.pdf
Back to Top